Balance Sheet Data

Boston Scientific Corporation (BSX)

$66.545

-0.13 (-0.19%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 2171,7341,9259288651,507.491,625.191,752.081,888.882,036.35
Total Cash (%)
Account Receivables 1,9331,5311,7781,9702,2282,443.612,634.392,840.083,061.823,300.87
Account Receivables (%)
Inventories 1,5791,3511,6101,8672,4842,273.482,450.982,642.342,848.653,071.06
Inventories (%)
Accounts Payable 542513794862942930.781,003.461,081.801,166.261,257.32
Accounts Payable (%)
Capital Expenditure -461-376-554-612-800-712.05-767.65-827.58-892.20-961.86
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.